-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LsjZb0QAP7Hbkg2jmMNGPe6kwS78/9Dl45aCP21Xt5n2r/WKZ9u30iQ+hzGE2Mqy mjxYK5NVdbtcAGpi2sS8kQ== 0001213900-10-002568.txt : 20100621 0001213900-10-002568.hdr.sgml : 20100621 20100621160159 ACCESSION NUMBER: 0001213900-10-002568 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100621 DATE AS OF CHANGE: 20100621 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UNITED AMERICAN HEALTHCARE CORP CENTRAL INDEX KEY: 0000867963 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 382526913 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-42157 FILM NUMBER: 10908128 BUSINESS ADDRESS: STREET 1: 300 RIVER PLACE, SUITE 4950 CITY: DETROIT STATE: MI ZIP: 48207 BUSINESS PHONE: 3133930200 MAIL ADDRESS: STREET 1: 300 RIVER PLACE STREET 2: SUITE 4950 CITY: DETROIT STATE: MI ZIP: 48207-2602 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: STRATEGIC TURNAROUND EQUITY PARTNERS LP CAYMAN CENTRAL INDEX KEY: 0001372509 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: PO BOX 2150 GT 4TH FLOOR STREET 2: 1 CAYMAN FINANCIAL CENTER CITY: GRAND CAYMAN STATE: E9 ZIP: 00000 BUSINESS PHONE: 212 247 0581 MAIL ADDRESS: STREET 1: PO BOX 2150 GT 4TH FLOOR STREET 2: 1 CAYMAN FINANCIAL CENTER CITY: GRAND CAYMAN STATE: E9 ZIP: 00000 SC 13D/A 1 sc13da13_strategic.htm SCHEDULE 13D/A sc13da13_strategic.htm


SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
SCHEDULE 13D
 
(Rule 13d-101)
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)
(AMENDMENT NO. 13) 1
 
United American Healthcare Corporation
(Name of Issuer)
 
Common Stock, $0.001 par value per share
(Title of Class of Securities)
 
90934C105
(CUSIP Number)
 
Strategic Turnaround Equity Partners, LP (Cayman)
c/o Galloway Capital Management, LLC
720 Fifth Avenue, 10th Floor
New York, New York 10019
(212)  247-0581
Attn: Gary Herman

With a copy to

Olshan Grundman Frome Rosenzweig & Wolosky, LLP
65 East 55th Street
New York, NY 10019
(212) 451-2300
Thomas J. Fleming, Esq.

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

June  21, 2010
(Date of Event Which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.
 
Note.  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.
 
See Rule 13d-7(b) for other parties to whom copies are to be sent.
 
 
 

1 The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
1

 
 
CUSIP No. 90934C105
13D
 
     
1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Strategic Turnaround Equity Partners, LP                                                                                 (Cayman)           98-0498777
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                                                                                                                         (a) o
                                                                             (b) x
3
SEC USE ONLY
4
SOURCE OF FUNDS *   WC
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2 (e)      o
6
CITIZENSHIP OR PLACE OF ORGANIZATION  Cayman Islands
NUMBER OF
SHARES
7
SOLE VOTING POWER                                                   0
BENEFICIALLY
OWNED BY
8
SHARED VOTING POWER                                            464,679
EACH
REPORTING
9
SOLE DISPOSITIVE POWER                                          0
PERSON WITH
10
SHARED DISPOSITIVE POWER                                   464,679
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
  464,679 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 115.69% (1)
14
TYPE OF REPORTING PERSON                                                                       PN
 
(1)  
On the basis of 8,164,117 shares of Common Stock reported by the Company to be issued and outstanding as of March 31, 2010 in the Company’s Form 10-Q filed with the Securities and Exchange Commission on May  17, 2010.
 
*SEE INSTRUCTIONS BEFORE FILLING OUT!
 
 
2

 
 
CUSIP No. 90934C105
13D
 
     
1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Galloway Capital Management, LLC                                                                                  n/a
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                                                                                                     (a)  o
                                                         (b) x
3
SEC USE ONLY
4
SOURCE OF FUNDS *   N/A
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2 (e)      o
6
CITIZENSHIP OR PLACE OF ORGANIZATION  Delaware
NUMBER OF
SHARES
7
SOLE VOTING POWER                                                   0
BENEFICIALLY
OWNED BY
8
SHARED VOTING POWER                                            464,679
EACH
REPORTING
9
SOLE DISPOSITIVE POWER                                          0
PERSON WITH
10
SHARED DISPOSITIVE POWER                                   464,679
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
464,679 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 115.69% (1)
14
TYPE OF REPORTING PERSON                                                                       OO
 
(1)  
On the basis of 8,164,117 shares of Common Stock reported by the Company to be issued and outstanding as of March 31, 2010 in the Company’s Form 10-Q filed with the Securities and Exchange Commission on May  17, 2010.
 
 
3

 
 
*SEE INSTRUCTIONS BEFORE FILLING OUT!
 
CUSIP No. 90934C105
13D
 
     
1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Gary L. Herman N/A
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                                                                                                (a) o
                                                    (b) x
3
SEC USE ONLY
4
SOURCE OF FUNDS *   PF
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2 (e)      o
6
CITIZENSHIP OR PLACE OF ORGANIZATION  United States
NUMBER OF
SHARES
7
SOLE VOTING POWER                                                   5,400 (1)
BENEFICIALLY
OWNED BY
8
SHARED VOTING POWER                                            464,679
EACH
REPORTING
9
SOLE DISPOSITIVE POWER                                          5,400 (1)
PERSON WITH
10
SHARED DISPOSITIVE POWER                                   464,679
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
470,079  (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 115.76% (2)
14
TYPE OF REPORTING PERSON                                                                       IN
 
(1)  
This includes 1,050 shares of common stock held by FBR, Inc., an entity over which Mr. Herman has investment and voting discretion.
 
(2)  
On the basis of 8,164,117 shares of Common Stock reported by the Company to be issued and outstanding as of March 31, 2010 in the Company’s Form 10-Q filed with the Securities and Exchange Commission on May  17, 2010.
 
*SEE INSTRUCTIONS BEFORE FILLING OUT!
 
 
4

 

CUSIP No. 90934C105
13D
 
     
1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Bruce Galloway                                                                                               N/A
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                                                                                                     (a) o
                                                         (b) x
3
SEC USE ONLY
4
SOURCE OF FUNDS *   N/A
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2 (e)      o
6
CITIZENSHIP OR PLACE OF ORGANIZATION  United States
NUMBER OF
SHARES
7
SOLE VOTING POWER                                                   350,284(1)
BENEFICIALLY
OWNED BY
8
SHARED VOTING POWER                                            464,679
EACH
REPORTING
9
SOLE DISPOSITIVE POWER                                          350,284 (1)
PERSON WITH
10
SHARED DISPOSITIVE POWER                                   464,679
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 814,963 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11         9.98% (2)
14
TYPE OF REPORTING PERSON                                                                       IN
 
(1)  
This includes 268,484 shares of common stock held by the Bruce Galloway, IRA, 18,100 shares of common stock held by Mr. Galloway, 20,775 shares of common stock owned by Mr. Galloway’s son for which Mr. Galloway has the power to vote and dispose, 15,050 shares of common stock owned by Mr. Galloway’s daughter for which Mr. Galloway has the power to vote and dispose, 12,253 shares held by T3 Capital Fund, LP for which Mr. Galloway retains investment and voting discretion, 2,930 shares held by RexonGalloway Capital Growth, LLC for which Mr. Galloway retains investment and voting discretion, and 12,692 shares of common stock held by Jacombs Investments, Inc. for which Mr. Galloway retains investment and voting discretion.
 
(2)  
On the basis of 8,164,117 shares of Common Stock reported by the Company to be issued and outstanding as of March 31, 2010 in the Company’s Form 10-Q filed with the Securities and Exchange Commission on May  17, 2010.
 
*SEE INSTRUCTIONS BEFORE FILLING OUT!

 
5

 
 
Item 4.
Purpose of Transaction
 
On June 21, 2010 Bruce Galloway a Director of the Issuer and a member of the Strategic Group sent a letter to the Issuer protesting to the recent transaction and that Management did not have the necessary approvals to go forward on the transaction.
 
 
6

 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
Strategic Turnaround Equity Partners, LP (Cayman)
 
June 21, 2010
By:/s/ Gary Herman
 
Name: Gary Herman
 
Title: Managing Member of Galloway Capital
Management LLC, the General Partner of Strategic
Turnaround Equity Partners, LP (Cayman)
 
Galloway Capital Management, LLC
 
June 21, 2010
/s/ Bruce Galloway
 
Name: Bruce Galloway
 
Title: Managing Member
 
June 21, 2010
/s/ Gary L. Herman
 
 
Gary L. Herman
 
June 21, 2010
/s/ Bruce Galloway
 
Bruce Galloway
 

7
-----END PRIVACY-ENHANCED MESSAGE-----